It had been shown previously that the downregulation of Sororin leads to reduced ERK phosphorylation at Y202/T204 in human colorectal cancer (CRC) and human hepatocellular carcinomas (HCC)61,62. This evidence concerns the gene CDCA5 and colorectal carcinoma.